compound 3k: Hybrid drug combination: Combination of ferulic acid and metformin as anti-diabetic therapy

GSK2334470 : Disruption of Autophagic Flux and Treatment with the PDPK1 Inhibitor GSK2334470 Synergistically Inhibit Renal Cell Carcinoma Pathogenesis

MK-8776 : Molecular mechanisms restoring olaparib efficacy through ATR/CHK1 pathway inhibition in olaparib-resistant BRCA1/2MUT ovarian cancer models

PD-0332991 : Monitoring of Hematologic, Cardiac, and Hepatic Function in Post-Menopausal Women with HR+/ HER22 Metastatic Breast Cancer<